Back to Search
ROBERT SMITH, M.D.
M.D.
Specialist
NPI: 1427139658Individual
Specialties, Licenses & Credentials
SpecialistPrimary
Specialist
Code: 174400000X
D97719(TX)
Clinical Trials (4)
4
Linked Trials
0
Recruiting
3
With Results
Varenicline Effects In Schizophrenic Smokers
NCT00548470COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Pioglitazone as a Treatment for Lipid and Glucose Abnormalities In Patients With Schizophrenia
NCT00231894COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Varenicline for Cognitive Deficits and Cigarette Smoking in Schizophrenia - Efficacy and Predictors
NCT00802919COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Comparative Effects of Chronic Treatment With Olanzapine and Risperidone on Glucose and Lipid Metabolism
NCT00287820COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Research & Publications (20)
Nicotine receptor partial agonists for smoking cessation.
PMID 37142273·Cochrane Database Syst Rev·2023
1-meta
Varenicline Effects on Smoking, Cognition, and Psychiatric Symptoms in Schizophrenia: A Double-Blind Randomized Trial.
PMID 26730716·PLoS One·2016
4-observational
Effects of pioglitazone on metabolic abnormalities, psychopathology, and cognitive function in schizophrenic patients treated with antipsychotic medication: a randomized double-blind study.
PMID 23200554·Schizophr Res·2013
2-rct
Olanzapine and risperidone effects on appetite and ghrelin in chronic schizophrenic patients.
PMID 22475524·Psychiatry Res·2012
2-rct
Effects of olanzapine and risperidone on lipid metabolism in chronic schizophrenic patients with long-term antipsychotic treatment: a randomized five month study.
PMID 20457512·Schizophr Res·2010
2-rct
Effects of olanzapine and risperidone on glucose metabolism and insulin sensitivity in chronic schizophrenic patients with long-term antipsychotic treatment: a randomized 5-month study.
PMID 19814947·J Clin Psychiatry·2009
4-observational
Cognitive and antismoking effects of varenicline in patients with schizophrenia or schizoaffective disorder.
PMID 19251401·Schizophr Res·2009
3-trial
Ethanol consumption does not promote weight gain in female mice.
PMID 19136820·Ann Nutr Metab·2008
7-preclinical
Picking a frame for communicating about genetics: stigmas or challenges.
PMID 17476468·J Genet Couns·2007
8-other
Ghrelin receptor (GHS-R1A) agonists show potential as interventive agents during aging.
PMID 18056963·Ann N Y Acad Sci·2007
6-review
The cost of event-based prospective memory: salient target events.
PMID 17576150·J Exp Psychol Learn Mem Cogn·2007
8-other
Social sides of health risks: stigma and collective efficacy.
PMID 17461752·Health Commun·2007
8-other
The impact of stigma, experience, and group referent on HIV risk assessments and HIV testing intentions in Namibia.
PMID 16930796·Soc Sci Med·2006
8-other
Developments in ghrelin biology and potential clinical relevance.
PMID 16213742·Trends Endocrinol Metab·2005
6-review
Molecular endocrinology and physiology of the aging central nervous system.
PMID 15561803·Endocr Rev·2005
6-review
Growth hormone secretagogues: prospects and potential pitfalls.
PMID 15261841·Best Pract Res Clin Endocrinol Metab·2004
6-review
Quantitation of reticulated platelets in healthy dogs and in nonthrombocytopenic dogs with clinical disease.
PMID 12019476·Vet Clin Pathol·2002
7-preclinical
Microcurrent therapies: emerging theories of physiological information processing.
PMID 12016342·NeuroRehabilitation·2002
6-review
Growth hormone secretagogue receptor family members and ligands.
PMID 11322507·Endocrine·2001
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 11803 SOUTH FREEWAY, SUITE 105
FT WORTH, TX 76115 - Phone
- (817) 293-7022
Quick Facts
- NPI
- 1427139658
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 4
- Publications
- 20
Are you this provider?
Claim Your Profile